Template:Ceftizoxime: Difference between revisions

Revision as of 03:41, 31 December 2013

@@ Line 2: / Line 2: @@
 ! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Ceftizoxime|{{fontcolor|#6C7B8B|Ceftizoxime}}]]'''''
 |-
-! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left |Cefizox <sup>®</sup> FDA Package Insert
+! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | CEFIZOX<sup>®</sup> FDA Package Insert
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Ceftizoxime description|Description]]
@@ Line 19: / Line 19: @@
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Ceftizoxime overdosage|Overdosage]]
+|-
+! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Ceftizoxime clinical studies|Clinical Studies]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Ceftizoxime dosage and administration|Dosage and Administration]]
-|-
-! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Ceftizoxime clinical studies|Clinical Studies]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Ceftizoxime how supplied|How Supplied]]